Robert L Coleman (Robert Coleman)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 56

Top Topics

Endometrial Cancer

Minimally Invasive

Epidermal Growth Factor Receptor

Top Venues

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Shubham Agrawal, Rushad Patell, Laura E Dodge, Jennifer W Pegher, Robert L Coleman, David Michael Waterhouse, Daniel Aaron Roberts, Deepa Rangachari
Defining the Educational Needs for a Community-Based Hematology/Oncology Career: A National Needs Assessment. JCO oncology practice (2024)
Robert L Coleman, Domenica Lorusso, Ana Oaknin, Sabrina Chiara Cecere, Hannelore G Denys, Nicoletta Colombo, Toon Van Gorp, Jason A Konner, Margarita Romeo Marin, Philipp Harter, Conleth Murphy, Yuemei Wang, Brooke Esteves, Michael Method, Ursula A Matulonis
Mirvetuximab soravtansine in folate receptor alpha (FRα)-high platinum-resistant ovarian cancer: final overall survival and post hoc sequence of therapy subgroup results from the SORAYA trial. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 34 (8) (2024)
Ignace Vergote, José Alejandro Pérez-Fidalgo, Giorgio Valabrega, Bradley J Monk, Thomas Herzog, David Cibula, Nicoletta Colombo, Bhavana Pothuri, Jalid Sehouli, Jacob Korach, Joyce Barlin, Christos A Papadimitriou, Toon Van Gorp, Debra L Richardson, Michael McCarthy, Yoland Antill, Mansoor Raza Mirza, Kai Li, Pratheek Kalyanapu, Brian M Slomovitz, Robert L Coleman
ENGOT-EN20/GOG-3083/XPORT-EC-042 - A phase III, randomized, placebo-controlled, double-blind, multicenter trial of selinexor in maintenance therapy after systemic therapy for patients with p53 wild-type, advanced, or recurrent endometrial carcinoma: rationale, methods, and trial design. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 34 (8) (2024)
Robert L Coleman, Domenica Lorusso, Ana Oaknin, Sabrina Chiara Cecere, Hannelore G Denys, Nicoletta Colombo, Toon Van Gorp, Jason A Konner, Margarita Romeo Marin, Philipp Harter, Conleth Murphy, Yuemei Wang, Brooke Esteves, Michael Method, Ursula A Matulonis
Mirvetuximab soravtansine in folate receptor alpha (FRα)-high platinum-resistant ovarian cancer: final overall survival and post hoc sequence of therapy subgroup results from the SORAYA trial. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 34 (8) (2024)
Shubham Agrawal, Rushad Patell, Laura E Dodge, Jennifer W Pegher, Robert L Coleman, David Michael Waterhouse, Daniel Aaron Roberts, Deepa Rangachari
Defining the Educational Needs for a Community-Based Hematology/Oncology Career: A National Needs Assessment. JCO oncology practice 20 (6) (2024)
Ignace Vergote, José Alejandro Pérez-Fidalgo, Giorgio Valabrega, Bradley J Monk, Thomas Herzog, David Cibula, Nicoletta Colombo, Bhavana Pothuri, Jalid Sehouli, Jacob Korach, Joyce Barlin, Christos A Papadimitriou, Toon Van Gorp, Debra L Richardson, Michael McCarthy, Yoland Antill, Mansoor Raza Mirza, Kai Li, Pratheek Kalyanapu, Brian M Slomovitz, Robert L Coleman
ENGOT-EN20/GOG-3083/XPORT-EC-042 - A phase III, randomized, placebo-controlled, double-blind, multicenter trial of selinexor in maintenance therapy after systemic therapy for patients with p53 wild-type, advanced, or recurrent endometrial carcinoma: rationale, methods, and trial design. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 34 (8) (2024)
Ignace Vergote, José Alejandro Pérez-Fidalgo, Giorgio Valabrega, Bradley J Monk, Thomas Herzog, David Cibula, Nicoletta Colombo, Bhavana Pothuri, Jalid Sehouli, Jacob Korach, Joyce Barlin, Christos A Papadimitriou, Toon Van Gorp, Debra L Richardson, Michael McCarthy, Yoland Antill, Mansoor Raza Mirza, Kai Li, Pratheek Kalyanapu, Brian M Slomovitz, Robert L Coleman
ENGOT-EN20/GOG-3083/XPORT-EC-042 - A phase III, randomized, placebo-controlled, double-blind, multicenter trial of selinexor in maintenance therapy after systemic therapy for patients with p53 wild-type, advanced, or recurrent endometrial carcinoma: rationale, methods, and trial design. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 34 (8) (2024)
Robert L Coleman, Domenica Lorusso, Ana Oaknin, Sabrina Chiara Cecere, Hannelore G Denys, Nicoletta Colombo, Toon Van Gorp, Jason A Konner, Margarita Romeo Marin, Philipp Harter, Conleth Murphy, Yuemei Wang, Brooke Esteves, Michael Method, Ursula A Matulonis
Mirvetuximab soravtansine in folate receptor alpha (FRα)-high platinum-resistant ovarian cancer: final overall survival and post hoc sequence of therapy subgroup results from the SORAYA trial. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2024)
Robert L Coleman, Domenica Lorusso, Ana Oaknin, Sabrina Chiara Cecere, Hannelore G Denys, Nicoletta Colombo, Toon Van Gorp, Jason A Konner, Margarita Romeo Marin, Philipp Harter, Conleth Murphy, Yuemei Wang, Brooke Esteves, Michael Method, Ursula A Matulonis
Mirvetuximab soravtansine in folate receptor alpha (FRα)-high platinum-resistant ovarian cancer: final overall survival and post hoc sequence of therapy subgroup results from the SORAYA trial. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 34 (8) (2024)
Selina Sfeir, Lucy Allen, Marc Daniël Algera, Rhett Morton, Rhonda Farrell, Donal J Brennan, Willemien J van Driel, Marcus J Rijken, Mary Eiken, Sudha S Sundar, Robert L Coleman, null null
Exploring global barriers to optimal ovarian cancer care: thematic analysis. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 34 (9) (2024)
Angelina Tjokrowidjaja, Michael L Friedlander, Jonathan A Ledermann, Robert L Coleman, Mansoor Raza Mirza, Ursula A Matulonis, Eric Pujade-Lauraine, Sarah Sally J Lord, Clare L Scott, Sandra Goble, Whitney York, Chee Khoon Lee, null null
Poor Concordance Between Cancer Antigen-125 and RECIST Assessment for Progression in Patients With Platinum-Sensitive Relapsed Ovarian Cancer on Maintenance Therapy With a Poly(ADP-ribose) Polymerase Inhibitor. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Angelina Tjokrowidjaja, Michael L Friedlander, Jonathan A Ledermann, Robert L Coleman, Mansoor Raza Mirza, Ursula A Matulonis, Eric Pujade-Lauraine, Sarah Sally J Lord, Clare L Scott, Sandra Goble, Whitney York, Chee Khoon Lee, null null
Poor Concordance Between Cancer Antigen-125 and RECIST Assessment for Progression in Patients With Platinum-Sensitive Relapsed Ovarian Cancer on Maintenance Therapy With a Poly(ADP-ribose) Polymerase Inhibitor. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Angelina Tjokrowidjaja, Michael L Friedlander, Jonathan A Ledermann, Robert L Coleman, Mansoor Raza Mirza, Ursula A Matulonis, Eric Pujade-Lauraine, Sarah Sally J Lord, Clare L Scott, Sandra Goble, Whitney York, Chee Khoon Lee, null null
Poor Concordance Between Cancer Antigen-125 and RECIST Assessment for Progression in Patients With Platinum-Sensitive Relapsed Ovarian Cancer on Maintenance Therapy With a Poly(ADP-ribose) Polymerase Inhibitor. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Ignace Vergote, José Alejandro Pérez-Fidalgo, Giorgio Valabrega, Bradley J Monk, Thomas Herzog, David Cibula, Nicoletta Colombo, Bhavana Pothuri, Jalid Sehouli, Jacob Korach, Joyce Barlin, Christos A Papadimitriou, Toon Van Gorp, Debra L Richardson, Michael McCarthy, Yoland Antill, Mansoor Raza Mirza, Kai Li, Pratheek Kalyanapu, Brian M Slomovitz, Robert L Coleman
ENGOT-EN20/GOG-3083/XPORT-EC-042 - A phase III, randomized, placebo-controlled, double-blind, multicenter trial of selinexor in maintenance therapy after systemic therapy for patients with p53 wild-type, advanced, or recurrent endometrial carcinoma: rationale, methods, and trial design. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2024)
Pedro T Ramirez, Kristy P Robledo, Michael Frumovitz, Lina Caicedo, Reitan Ribeiro, Aldo Lopez, Xiaojian Yan, David Isla, Renato Moretti Marques, Marcus Q Bernardini, Val Gebski, Rebecca Asher, Vanessa Behan, Robert L Coleman, Andreas Obermair
LACC Trial: Final Analysis on Overall Survival Comparing Open Versus Minimally Invasive Radical Hysterectomy for Early-Stage Cervical Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Pedro T Ramirez, Kristy P Robledo, Michael Frumovitz, Lina Caicedo, Reitan Ribeiro, Aldo Lopez, Xiaojian Yan, David Isla, Renato Moretti Marques, Marcus Q Bernardini, Val Gebski, Rebecca Asher, Vanessa Behan, Robert L Coleman, Andreas Obermair
LACC Trial: Final Analysis on Overall Survival Comparing Open Versus Minimally Invasive Radical Hysterectomy for Early-Stage Cervical Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (23) (2024)
Selina Sfeir, Lucy Allen, Marc Daniël Algera, Rhett Morton, Rhonda Farrell, Donal J Brennan, Willemien J van Driel, Marcus J Rijken, Mary Eiken, Sudha S Sundar, Robert L Coleman, null null
Exploring global barriers to optimal ovarian cancer care: thematic analysis. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2024)
Anca Chelariu-Raicu, Sven Mahner, Kathleen Nadine Moore, Domenica Lorusso, Robert L Coleman
Integrating antibody drug conjugates in the management of gynecologic cancers. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 33 (3) (2023)
John J Nemunaitis, Laura Stanbery, David Willoughby, Ernest Bognar, Scott Brun, Adam Walter, Bradley J Monk, Rodney P Rocconi, Khalil Choucair, Robert L Coleman
Clonal Neoantigen: Emerging "Mechanism-based" Biomarker of Immunotherapy Response. Cancers 15 (23) (2023)
Rachel N Grisham, Ignace Vergote, Susana Banerjee, Esther Drill, Elsa Kalbacher, Mansoor Raza Mirza, Ignacio Romero, Peter Vuylsteke, Robert L Coleman, Felix Hilpert, Amit M Oza, Anneke M Westermann, Martin K Oehler, Sandro Pignata, Carol Aghajanian, Nicoletta Colombo, David Cibula, Kathleen M Moore, Josep M Del Campo, Regina Berger, Christian Marth, Jalid Sehouli, David M O'Malley, Cristina Churruca, Gunnar B Kristensen, Andrew R Clamp, John Farley, Gopakumar V Iyer, Isabelle L Ray-Coquard, Bradley J Monk
Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib vs Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Ainhoa Madariaga, Robert L Coleman, Antonio Gonzáles Martin
Novel therapies leading to a new landscape in gynecologic tumors. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 33 (3) (2023)
Seif Tarek El-Swaify, Mohamed Laban, Sara H Ali, Mohamed Sabbour, Mazen A Refaat, Nourhan Farrag, Eman A Ibrahim, Robert L Coleman
Can fluorescence-guided surgery improve optimal surgical treatment for ovarian cancer? A systematic scoping review of clinical studies. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2023)
Ainhoa Madariaga, Robert L Coleman, Antonio Gonzáles Martin
Novel therapies leading to a new landscape in gynecologic tumors. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 33 (3) (2023)
Ursula A Matulonis, Domenica Lorusso, Ana Oaknin, Sandro Pignata, Andrew Dean, Hannelore G Denys, Nicoletta Colombo, Toon Van Gorp, Jason A Konner, Margarita Romeo Marin, Philipp Harter, Conleth G Murphy, Jiuzhou Wang, Elizabeth Noble, Brooke Esteves, Michael Method, Robert L Coleman
Efficacy and Safety of Mirvetuximab Soravtansine in Patients With Platinum-Resistant Ovarian Cancer With High Folate Receptor Alpha Expression: Results From the SORAYA Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Anca Chelariu-Raicu, Sven Mahner, Kathleen Nadine Moore, Domenica Lorusso, Robert L Coleman
Integrating antibody drug conjugates in the management of gynecologic cancers. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 33 (3) (2023)
Robert L Coleman
PARP inhibitor era: current status and future directions. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2023)
Ainhoa Madariaga, Robert L Coleman, Antonio Gonzáles Martin
Novel therapies leading to a new landscape in gynecologic tumors. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 33 (3) (2023)
Gabriel Levin, Ross Harrison, Jonathan A Ledermann, Raanan Meyer, Robert L Coleman, Pedro T Ramirez
Evaluating open access publication and research impact in gynecologic oncology. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2023)
Hannah Karpel, Brian Slomovitz, Robert L Coleman, Bhavana Pothuri
Biomarker-driven therapy in endometrial cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 33 (3) (2023)
Hannah Karpel, Brian Slomovitz, Robert L Coleman, Bhavana Pothuri
Biomarker-driven therapy in endometrial cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 33 (3) (2023)
Giuseppe Caruso, Robert L Coleman, Giovanni Aletti, Francesco Multinu, Andrea Botticelli, Innocenza Palaia, William A Cliby, Nicoletta Colombo
Systemic therapy de-escalation in advanced ovarian cancer: a new era on the horizon? International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2023)
Ursula A Matulonis, Domenica Lorusso, Ana Oaknin, Sandro Pignata, Andrew Dean, Hannelore G Denys, Nicoletta Colombo, Toon Van Gorp, Jason A Konner, Margarita Romeo Marin, Philipp Harter, Conleth G Murphy, Jiuzhou Wang, Elizabeth Noble, Brooke Esteves, Michael Method, Robert L Coleman
Reply to Z.R. McCaw et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Hannah Karpel, Brian Slomovitz, Robert L Coleman, Bhavana Pothuri
Biomarker-driven therapy in endometrial cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 33 (3) (2023)
Anca Chelariu-Raicu, Sven Mahner, Kathleen Nadine Moore, Domenica Lorusso, Robert L Coleman
Integrating antibody drug conjugates in the management of gynecologic cancers. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 33 (3) (2023)
Benoit You, Christopher Purdy, Larry J Copeland, Elizabeth M Swisher, Michael A Bookman, Gini F Fleming, Robert L Coleman, Leslie M Randall, Krishnansu S Tewari, Bradley J Monk, Robert S Mannel, Joan L Walker, Fabio Cappuccini, David E Cohn, Mahvish Muzaffar, David G Mutch, Andrea E Wahner Hendrickson, Lainie Martin, Olivier Colomban, Robert A Burger
Identification of Patients With Ovarian Cancer Experiencing the Highest Benefit From Bevacizumab in the First-Line Setting on the Basis of Their Tumor-Intrinsic Chemosensitivity (KELIM): The GOG-0218 Validation Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (34) (2022)
Bradley J Monk, Christine Parkinson, Myong Cheol Lim, David M O'Malley, Ana Oaknin, Michelle K Wilson, Robert L Coleman, Domenica Lorusso, Paul Bessette, Sharad Ghamande, Athina Christopoulou, Diane Provencher, Emily Prendergast, Fuat Demirkiran, Olga Mikheeva, Oladapo O Yeku, Anita Chudecka-Glaz, Michael Schenker, Ramey D Littell, Tamar Safra, Hung-Hsueh Chou, Mark A Morgan, Vít Drochýtek, Joyce N Barlin, Toon Van Gorp, Frederick Rand Ueland, Gabriel Lindahl, Charles Anderson, Dearbhaile C Collins, Kathleen M Moore, Frederic Marmé, Shannon Neville Westin, Iain A McNeish, Danny Shih, Kevin K Lin, Sandra Goble, Stephanie Hume, Keiichi Fujiwara, Rebecca S Kristeleit
A Randomized, Phase III Trial to Evaluate Rucaparib Monotherapy as Maintenance Treatment in Patients With Newly Diagnosed Ovarian Cancer (ATHENA-MONO/GOG-3020/ENGOT-ov45). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (34) (2022)
Benoit You, Vasudha Sehgal, Balakrishna Hosmane, Xin Huang, Peter J Ansell, Minh H Dinh, Katherine Bell-McGuinn, Xizhi Luo, Gini F Fleming, Michael L Friedlander, Michael A Bookman, Kathleen M Moore, Karina Dahl Steffensen, Robert L Coleman, Elizabeth M Swisher
CA-125 KELIM as a Potential Complementary Tool for Predicting Veliparib Benefit: An Exploratory Analysis From the VELIA/GOG-3005 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Tracy Sherertz, Anuja Jhingran, Matthew Biagioli, David Gaffney, Mohamed Elshaikh, Robert L Coleman, Matthew Harkenrider, Elizabeth A Kidd, Shruti Jolly, Catheryn Yashar, Lorraine Portelance, Andrew Wahl, Aradhana Venkatesan, Linna Li, William Small, null null
Executive summary of the American Radium Society appropriate use criteria for management of uterine clear cell and serous carcinomas. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2022)
Alessandro D Santin, Ignace Vergote, Antonio González-Martín, Kathleen Moore, Ana Oaknin, Ignacio Romero, Sami Diab, Larry J Copeland, Bradley J Monk, Robert L Coleman, Thomas J Herzog, Jonathan Siegel, Linda Kasten, Andreas Schlicker, Anke Schulz, Karl Köchert, Annette O Walter, Barrett H Childs, Cem Elbi, Iurie Bulat
Safety and activity of anti-mesothelin antibody-drug conjugate anetumab ravtansine in combination with pegylated-liposomal doxorubicin in platinum-resistant ovarian cancer: multicenter, phase Ib dose escalation and expansion study. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2022)
Lauren Shore Prescott, Ignace Vergote, Charlotte C Sun, Diane C Bodurka, Robert L Coleman
Transfusion use and effect on progression-free, overall survival, and quality of life in upfront treatment of advanced epithelial ovarian cancer: evaluation of the European Organization for Research and Treatment EORTC-55971 Cohort. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2022)
Bradley J Monk, Keiichi Fujiwara, David M O'Malley, Robert L Coleman, Iain A McNeish, Kevin K Lin, Stephanie Hume, Rebecca S Kristeleit
Reply to C. Marchetti et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Robin L Jones, Thomas J Herzog, Shreyaskumar R Patel, Margaret von Mehren, Scott M Schuetze, Brian Andrew Van Tine, Robert L Coleman, Roland Knoblauch, Spyros Triantos, Peter Hu, Waleed Shalaby, Tracy McGowan, Bradley J Monk, George D Demetri
Cardiac safety of trabectedin monotherapy or in combination with pegylated liposomal doxorubicin in patients with sarcomas and ovarian cancer. Cancer medicine 10 (11) (2021)
Paul DiSilvestro, Nicoletta Colombo, Philipp Harter, Antonio González-Martín, Isabelle L Ray-Coquard, Robert L Coleman
Maintenance Treatment of Newly Diagnosed Advanced Ovarian Cancer: Time for a Paradigm Shift? Cancers 13 (22) (2021)
Shannon Neville Westin, Marilyne Labrie, Jennifer K Litton, Aurora S Blucher, Yong Fang, Christopher P Vellano, Joseph R Marszalek, Ningping Feng, XiaoYan Ma, Allison L Creason, Bryan Fellman, Ying Yuan, Sanghoon Lee, Tae-Beom Kim, Jinsong Liu, Anca Chelariu-Raicu, Tsun Hsuan Chen, Nashwa Kabil, Pamela T Soliman, Michael Frumovitz, Katheleen M Schmeler, Amir A Jazaeri, Karen H Lu, Rashmi K Murthy, Larissa A Meyer, Charlotte C Sun, Anil K Sood, Robert L Coleman, Gordon B Mills
Phase Ib Dose Expansion and Translational Analyses of Olaparib in Combination with Capivasertib in Recurrent Endometrial, Triple-Negative Breast, and Ovarian Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (23) (2021)
Katelyn F Handley, Cristian Rodríguez-Aguayo, Shaolin Ma, Elaine Stur, Robiya Joseph, Emine Bayraktar, Santosh K Dasari, Nghi Nguyen, Reid T Powell, Mary Sobieski, Cristina Ivan, Mark Kim, Sujanitha Umamaheswaran, Deanna M Glassman, Yunfei Wen, Paola Amero, Clifford Stephen, Robert L Coleman, Yosef Landesman, Shannon Neville Westin, Prahlad T Ram, Anil K Sood
Rational Combination of CRM1 Inhibitor Selinexor and Olaparib Shows Synergy in Ovarian Cancer Cell Lines and Mouse Models. Molecular cancer therapeutics 20 (12) (2021)
Ana Oaknin, Amit M Oza, Domenica Lorusso, Carol Aghajanian, Andrew Dean, Nicoletta Colombo, Johanne I Weberpals, Andrew R Clamp, Giovanni Scambia, Alexandra Leary, Robert W Holloway, Margarita Amenedo Gancedo, Peter C Fong, Jeffrey C Goh, David M O'Malley, Deborah K Armstrong, Susana Banerjee, Jesus García-Donas, Elizabeth M Swisher, Terri Cameron, Lara Maloney, Sandra Goble, Jonathan A Ledermann, Robert L Coleman
Maintenance treatment with rucaparib for recurrent ovarian carcinoma in ARIEL3, a randomized phase 3 trial: The effects of best response to last platinum-based regimen and disease at baseline on efficacy and safety. Cancer medicine 10 (20) (2021)
Amit M Oza, Domenica Lorusso, Carol Aghajanian, Ana Oaknin, Andrew Dean, Nicoletta Colombo, Johanne I Weberpals, Andrew R Clamp, Giovanni Scambia, Alexandra Leary, Robert W Holloway, Margarita Amenedo Gancedo, Peter C Fong, Jeffrey C Goh, David M O'Malley, Deborah K Armstrong, Susana Banerjee, Jesús García-Donas, Elizabeth M Swisher, David Cella, Juliette Meunier, Sandra Goble, Terri Cameron, Lara Maloney, Ann-Christin Mörk, Josh Bedel, Jonathan A Ledermann, Robert L Coleman
Patient-Centered Outcomes in ARIEL3, a Phase III, Randomized, Placebo-Controlled Trial of Rucaparib Maintenance Treatment in Patients With Recurrent Ovarian Carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 38 (30) (2020)
Robert L Coleman
The role of secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer: what do the trials tell us? Journal of gynecologic oncology 32 (1) (2020)
Asaf Maoz, Marcia A Ciccone, Shinya Matsuzaki, Robert L Coleman, Koji Matsuo
Emerging serine-threonine kinase inhibitors for treating ovarian cancer. Expert opinion on emerging drugs 24 (4) (2020)
Shannon D Armbruster, Bryan M Fellman, Anuja Jhingran, Patricia J Eifel, Ann H Klopp, Robert L Coleman, Lois Michelle Ramondetta, Michael Frumovitz
A phase III study of transdermal granisetron versus oral ondansetron for women with gynecologic cancers receiving pelvic chemoradiation. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 29 (1) (2020)
Takahito M Miyake, Sunila Pradeep, Emine Bayraktar, Elaine Stur, Katelyn F Handley, Sherry Y Wu, Cristian Rodríguez-Aguayo, Ju-Seog Lee, Gabriel Lopez-Berestein, Robert L Coleman, Anil K Sood
NRG1/ERBB3 Pathway Activation Induces Acquired Resistance to XPO1 Inhibitors. Molecular cancer therapeutics 19 (8) (2020)
Mark Seungwook Kim, Shaolin Ma, Anca Chelariu-Raicu, Carola Leuschner, Hector W Alila, Sanghoon Lee, Robert L Coleman, Anil K Sood
Enhanced Immunotherapy with LHRH-R Targeted Lytic Peptide in Ovarian Cancer. Molecular cancer therapeutics 19 (11) (2020)
David S Hong, Nicole Concin, Ignace Vergote, Johann S de Bono, Brian M Slomovitz, Yvette Drew, Hendrik-Tobias Arkenau, Jean-Pascal Machiels, James F Spicer, Robert Jones, Martin D Forster, Nathalie Cornez, Christine Gennigens, Melissa L Johnson, Fiona C Thistlethwaite, Reshma A Rangwala, Srinivas Ghatta, Kristian Windfeld, Jeffrey R Harris, Ulrik Niels Lassen, Robert L Coleman
Tisotumab Vedotin in Previously Treated Recurrent or Metastatic Cervical Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (6) (2019)
Katherine C Kurnit, Shannon N Westin, Robert L Coleman
Microsatellite instability in endometrial cancer: New purpose for an old test. Cancer 125 (13) (2019)
Robert C Bast, Ursula A Matulonis, Anil K Sood, Ahmed A Ahmed, Adaobi E Amobi, Frances R Balkwill, Monicka Wielgos-Bonvallet, David D L Bowtell, James D Brenton, Joan S Brugge, Robert L Coleman, Giulio F Draetta, Kai Doberstein, Ronny I Drapkin, Mark A Eckert, Robert P Edwards, Kevin M Elias, Darren Ennis, Andrew Futreal, David M Gershenson, Roger A Greenberg, David G Huntsman, Jennifer Xiao Ye Ji, Elise C Kohn, Claudia Iavarone, Ernst R Lengyel, Douglas A Levine, Christopher J Lord, Zhen Lu, Gordon B Mills, Francesmary Modugno, Brad H Nelson, Kunle Odunsi, Jessica A Pilsworth, Robert K Rottapel, Daniel J Powell, Li Shen, Ie-Ming Shih, David R Spriggs, Josephine Walton, Kaiyang Zhang, Rugang Zhang, Lee Zou
Critical questions in ovarian cancer research and treatment: Report of an American Association for Cancer Research Special Conference. Cancer 125 (12) (2019)
Pamela T Soliman, Shannon N Westin, David A Iglesias, Bryan M Fellman, Ying Yuan, Qian Zhang, Melinda S Yates, Russell R Broaddus, Brian M Slomovitz, Karen H Lu, Robert L Coleman
Everolimus, Letrozole, and Metformin in Women with Advanced or Recurrent Endometrioid Endometrial Cancer: A Multi-Center, Single Arm, Phase II Study. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (3) (2019)